Ron Kurtz

President and Chief Executive Officer at RxSight

Board

Since 2016

Age

62 years

Education

Holds a B.A. in Biochemistry from Harvard College and an M.D. from the University of California, San Diego.

Tenure

Has served as President and Chief Executive Officer and board member of RxSight, Inc. since 2016.

Also at RxSight

Eric Weinberg

Co-President and Chief Commercial Officer

Ilya Goldshleger

Co-President and Chief Operating Officer

Shelley Thunen

Co-President and Chief Financial Officer

About

Dr. Ron Kurtz has led RxSight, Inc. as President and Chief Executive Officer since 2016, concurrently serving as a board member and steering the company in the medical technology field.

Before his tenure at RxSight, he co-founded LenSx Lasers, Inc., where he served as President and CEO, and later became General Manager at Alcon LenSx following its acquisition by Alcon Inc. He also co-founded IntraLase Corp., taking on the role of its initial President and CEO before the company transitioned into a publicly traded entity and was eventually acquired.

Academically, he earned a B.A. in Biochemistry from Harvard College and an M.D. from the University of California, San Diego, and further contributed to academia through roles at the University of California, Irvine and the University of Michigan.

$RXST Performance Under Ron Kurtz

Past Roles

Organization	Role	Date Range	Details
LenSx Lasers, Inc.	Co-founder, President and Chief Executive Officer; later General Manager of Alcon LenSx, Inc. following acquisition	N/A	Acquired by Alcon Inc. in 2010
IntraLase Corp. (NASDAQ: ILSE)	Co-founder, initial President and Chief Executive Officer; later held other senior leadership positions	N/A	Became publicly held in 2004 and was acquired by Advanced Medical Optics, Inc. (NYSE: AMO) in 2007
University of California, Irvine	Faculty Member	N/A	N/A
University of Michigan	Faculty Member	N/A	N/A

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Salary	$678,333	Regular payroll (annual)	Base salary increased from $645,000 in 2023 to $685,000 effective March 1, 2024; 6.2% YOY increase
Option Awards	$5,537,883	Grant Date: March 4, 2024	149,000 stock options granted at an exercise price of $56.07 per share; fair value determined in accordance with FASB ASC 718
All Other Compensation	$6,504	Annual	Includes 401(k) matching contributions (up to 2% of eligible compensation) and an Inventor Bonus of $1,500

Performance Compensation

Data from FY 2024

Performance Compensation Components

Metric	Weighting	Threshold / Minimum	Target	Maximum/Cap
Delighted Customers	30%	N/A	N/A	N/A
- New Product Launch	50% of segment	N/A	N/A	N/A
- Submission Readiness	25% of segment	N/A	N/A	N/A
- International Regulatory Approvals	25% of segment	N/A	N/A	N/A
Motivated Employees	30%	N/A	N/A	N/A
Shareholder Satisfaction	40%	N/A	N/A	N/A
- LAL/LAL+ Sales	40% of segment	N/A	N/A	N/A
- Manufacturing Initiatives	20% of segment	N/A	N/A	N/A
- Financial Metrics (Revenue, Gross Margin, Cash Expenditures)	40% of segment	Revenue: $125M, GM: 64%, Cash: $25M	Revenue: $135M, GM: 67%, Cash: $18M	Revenue: ≥$150M, GM: ≥68%, Cash: < $18M

Payout & Vesting Details

Detail	Value
Minimum Payout	25% of target
Target Payout	100% of target
Maximum Payout	150% of target
Actual Performance	112% of corporate goals leading to a bonus payout at 112% of target
Vesting Schedule (for Options)	4-year vesting with 1/48th vesting monthly starting 1 month after the vesting commencement date
Grant Date	March 4, 2024
Grant Date Fair Value	$5,537,883
Grant Date Stock Price	$56.07
Number of Stock Options	149,000 shares
Base Salary for Incentive Calculation	$685,000 (used for bonus target)